Overview

A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of diabetic macular edema.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate